Occurrence of the diffuse amyloid β-protein (Aβ) deposits with numerous Aβ-containing glial cells in the cerebral cortex of patients with Alzheimer's disease

GLIA

Volumn 25, Issue 4, 1999, Pages 324-331

  Akiyama, Haruhiko ^a   Mori, Hiroshi ^a   Saido, Takaomi ^b   Kondo, Hiromi ^a   Ikeda, Kenji ^a   McGeer, Patrick L ^c  

^a TOKYO METROPOLITAN INSTITUTE OF MEDICAL SCIENCE   (Japan)

^b RIKEN BRAIN SCIENCE INSTITUTE   (Japan)

^c UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

A 40; Astrocytes; Clearance; Degradation; Microglia; Uptake

Indexed keywords

AMYLOID BETA PROTEIN; AMYLOID BETA PROTEIN (1 43); AMYLOID BETA-PROTEIN (1-43); AUTACOID; BIOLOGICAL MARKER; PEPTIDE FRAGMENT;

AGED; ALZHEIMER DISEASE; ARTICLE; BRAIN CORTEX; CHEMISTRY; FEMALE; GLIA; HUMAN; IMMUNOHISTOCHEMISTRY; MALE; METABOLISM; MIDDLE AGED;

AGED; ALZHEIMER DISEASE; AMYLOID BETA-PROTEIN; BIOLOGICAL MARKERS; CEREBRAL CORTEX; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; INFLAMMATION MEDIATORS; MALE; MIDDLE AGED; NEUROGLIA; PEPTIDE FRAGMENTS;

EID: 0033557386     PISSN: 08941491     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1098-1136(19990215)25:4<324::AID-GLIA2>3.0.CO;2-5     Document Type: Article

References (34)

1. Akiyama H, McGeer PL. 1990. Brain microglia constitutively express β-2 integrins. J Neuroimmunol 30:81-93.
2. Akiyama H, Kawamata T, Yamada T, Tooyama I, Ishii T, McGeer PL. 1993a. Expression of intercellular adhesion molecule(ICAM)-1 by a subset of astrocytes in Alzheimer and some other degenerative neurological disorders. Acta Neuropathol 85:628-634.
3. Akiyama H, Tooyama I, Kawamata T, Ikeda K, McGeer PL. 1993b. Morphological diversities of CD44 positive astrocytes in the cerebral cortex of normal subjects and patients with Alzheimer's disease. Brain Res 632:249-259.
4. Akiyama H, Ikeda K, Katoh M, McGeer EG, McGeer PL. 1994. Expression of MRP14, 27E10, alpha-interferon and leucocyte common antigen by reactive microglia in postmortem human brain tissue. J Neuroimmunol 50:195-202.
5. Akiyama H, Schwab C, Mori H, Kametani F, McGeer PL. 1996a. Granules in glial cells of patients with Alzheimer's disease are immunopositive for C-terminal sequences of β-amyloid protein. Neurosci Lett 206:169-172.
6. Akiyama H, Kondo H, Mori H, Kametani F, Nishimura T, Ikeda K, Kato M, McGeer PL. 1996b. The amino-terminally truncated forms of amyloid β-protein in brain macrophages in the ischemic lesions of Alzheimer's disease patients. Neurosci Lett 219:115-118.
7. 43 (Aβ42). Neurochem Res 22:1499-1505.
8. Ard MD, Cole GM, Wei J, Mehrle AP, Fratkin JD. 1996. Scavenging of Alzheimer's amyloid β-protein by microglia in culture. J Neurosci Res 43:190-202.
9. Esler WP, Stimson ER, Chilardi JR, Vinters HV, Lee JP, Mantyh PW, Maggio JE. 1996. In vitro growth of Alzheimer's disease β-amyloid plaques display first-order kinetics. Biochemistry 35:74-757.
10. Greenberg BD. 1995. The COOH-terminus of the Alzheimer amyloid Aβ peptide: differences in length influence the process of amyloid deposition in Alzheimer brain and tell us something about relationships among parent. Amyloid Int J Exp Clin Invest 2:195-203.
11. Hulette CM, Downey BT, Burger PC. 1992. Macrophage markers in diagnostic neuropathology. Am J Surg Pathol 16:493-499.
12. Itagaki S, McGeer PL, Akiyama H, Zhu S, and Selkoe DJ. 1989. Relationship of microglia and astrocytes to amyloid deposits in Alzheimer disease. J Neuroimmunol 224:173-182.
13. Iwatsubo T, Odaka A, Suzuki N, Mizusawa H, Nukina N, Ihara Y. 1994. Visualization of Aβ42(43) and Aβ40 in senile plaques with end-specific Aβ monoclonals: evidence that an initially deposited species is Aβ42(43). Neuron 13:45-53.
14. Iwatsubo T, Saido T, Mann DMA, Lee VM-Y, Trojanowski JQ. 1996. Full-length amyloid-β(1-42(43)) and amino-terminally modified and truncated amyloid-β42(43) deposit in diffuse plaques. Am J Pathol 149:1823-1830.
15. Jarrett JT, Berger EP, Lansbury Jr PT. 1993. The carboxy terminus of the β amyloid protein is critical for the seeding of amyloid formation: implications for the pathogenesis of Alzheimer's disease. Biochemistry 32:4693-4697.
16. Jarrett JT, Lansbury Jr. PT. 1993. Seeding "one-dimensional crystallization" of amyloid: a pathogenic mechanism in Alzheimer's disease and scrapie? Cell 73:1055-1058.
17. LeBlanc AC, Xue R, Gambetti P. 1996. Amyloid precursor protein metabolism in primary cell cultures of neurons astrocytes, and microglia. J Neurochem 66:2300-2310.
18. Maggio JE, Stimson ER, Ghilardi JR, Allen CJ, Dahl CE, Whitcomb DC, Vigna SR, Vinters HV, Labenski ME, Mantyg PW. 1992. Reversible in vitro growth of Alzheimer disease β-amyloid plaques by deposition of labeled amyloid peptide. Proc Natl Acad Sci USA 89:5462-5466.
19. McDermott JR, Gibson AM. 1997. Degradation of Alzheimer's β-amyloid protein by human and rat brain peptidases. Neurochem Res 22:49-56.
20. Mori H, Takio K, Ogawara M, Selkoe DJ. 1992. Mass spectrometry of purified amyloid β protein in Alzheimer's disease. J Biol Chem 267:17082-17086.
21. Naidu A, Quon D, Cordell B. 1995. β -Amyloid peptide produced in vitro is degraded bv proteinases released by cultured cells. J Biol Chem 270:1369-1374.
22. Naslund J, Schierhorn A, Hellman U, Lannfelt L, Roses AD. 1994. Relative Abundance of Alzheimer Abeta Amyloid peptide variants in Alzheimer Disease and Normal Aging. Proc Natl Acad Sci USA 91:8378-8382.
23. Paresce DM, Ghosh RN, Maxfield FR. 1996. Microglial cells internalize aggregates of the Alzheimer's disease amyloid β-protein via a scavenger receptor. Neuron 17:553-565.
24. Prior R, D'Urso D, Frank R, Prikulis I, Cldeven S, Ihl R, Pavlakovic G. 1996. Selective binding of soluble Aβ1-40 and Aβ1-42 to a subset of senile plaques. Am J Pathol 148:1749-1756.
25. Qiu WQ, Ye Z, Kholodenko D, Seubert P, Selkoe DJ. 1997. Degradation of amyloid β-protein by metalloprotease secreted by microglia and other neural and non-neural cells. J Biol Chem 272:6641-6646.
26. N3 pE, in senile plaques. Neuron 14:457-466.
27. Saido TC, Yamao-Harigaya W, Iwatsubo T, Kawashima S. 1996. Amino-and carboxyl-terminal heterogeneity of ß-amyloid peptides deposited in human brain. Neurosci Lett 215:173-176.
28. Savage MJ, Kawooya JK, Pinsker LR, Emmons TL, Mistretta S, Siman R, Greenberg BD. 1995. Elevated Aβ levels in Alzheimer's disease brain are associated with selective accumulation of Aβ(42) in parenchymal amyloid plaques and both Aβ(40) and Aβ(42) in cerebrovascular deposits. Amyloid Int J Exp Clin Invest 2:234-240.
29. Selkoe DJ. 1994. Normal and abnormal biology of the β-amyloid precursor protein. Annu Rev Neurosci 17:489-517.
30. Shaffer LM, Dority MD, Gupta-Bansal R, Frederickson RCA, Younkin SG, Brunden KR. 1995. Amyloid β protein (Aβ) removal by neuroglial cells in culture. Neurobiol Aging 16:737-745.
31. Simons M, de Strooper B, Multhaup G, Tienari PJ, Dotti CG, Beyreuther K. 1996. Amyloidogenic processing of the human amyloid precursor protein in primary culture of rat hippocampal neurons. J Neurosci 16:899-908.
32. Tamaoka A, Sawamura N, Odaka A, Suzuki N, Mizusawa H, Shoji S, Mori H. 1995. Amyloid ß-protein 1-42/43 (Aβ1-42/43) in cerebellar diffuse plaques: enzyme-linked immunosorbent assay and immunocytochemical study. Brain Res 679:151-156.
33. Yamaguchi H, Sugihara S, Ishiguro K, Takashima A, Hirai S. 1995. Immunohistochemical analysis of COOH-termini of amyloid β protein (Aβ) using end-specific antisera for Aβ40 and Aβ42 in Alzheimer's disease and normal aging. Amyloid Int J Exp Clin Invest 2:7-16.
34. Zhao J, Paganimi L, Mucke L, Gordon M, Refolo L, Carman M, Sinha S, Oltersdorf T, Lieberburg I, McConlogue L. 1996. β-secretase processing of the β-amyloid precursor protein in transgenic mice is efficient in neurons but inefficient in astrocvtes. J Biol Chem 271:31407-31411.